Skip to main content

Table 7 HPV risk group among participants diagnosed with cervical cancer according to HIV status

From: Evaluation of hpv risk groups among women enrolled in the mulher cervical cancer screening study in Mozambique

 

All

(N = 30)

WLWH

(N = 19)

HIV negative

(N = 11)

p-value*

HPV16

12 (40.0%)

9 (47.4%)

3 (27.2%)

0.44

HPV18/45

8 (26.7%)

3 (15.8%)

5 (45.4%)

0.10

Other HR-HPV

5 (16.7%)

3 (15.8%)

2 (18.2%)

1.00

HPV16 & Other HR-HPV

5 (16.7%)

4 (21.0%)

1 (9.2%)

0.62

Any HPV16

17 (56.7%)

13 (68.4%)

4 (36.4%)

0.13

  1. WLWH: women living with HIV; HIV: human immunodeficiency virus; HPV: human papillomavirus